Just another update. I am no longer comfortable using Nolvadex as it has significant carcinogenic risks associated with it. I realize some here may disagree with that assessment, but the studies are out there, and there have been numerous FDA warnings.
So now I have exactly 24 hours to figure out my alternate method. Unfortunately Clomid also has carcinogenic effects, though apparently a little less than Nolva. And I took Clomid 6mg for nearly a year (great!). So I am not sure I want to add to that at all.
Guys are talking about taking “tore” and “rolax” (Fareston and Evista) as alternatives, but I don’t know anything about them.
I am REALLY doing well testosterone-wise on HCG alone. Can’t I just stop taking it and see if I keep chugging along naturally now?
I don’t know what to do. @KSman
[quote]The most significant findings of the chronic toxicity study were the confirmation of the potent hepatocarcinogenicity of tamoxifen, and the lack of any carcinogenic activity of toremifene under the condi- tions of 12-month daily exposure at high dose in female rats.
Tamoxi- fen-induced liver tumors were multiple and aggressive, leaving little normal tissue remaining by 15 months. Based additionally on clinical and necropsy observations, there was progression of the tamoxifen- induced liver tumors during the treatment-free period. In addition, the main cause of unscheduled death in tamoxifen-treated groups was liver neoplasia. The present report provides evidence, in compliance with GLP standards and in test groups of adequate size, for a major difference in the toxicology of these 2 drugs. The tamoxifen results concur with those from 2 other studies, which demonstrated liver tumors using a similar schedule of administration in Sprague-Dawley rats, but including a higher dose level (19, 20). Consistent with its hepatocarcinogenicity, tamoxifen induced an increased incidence of foci of hepatocellular alteration as early as 3 months in our sequential study. Foci have been established as the precursors of liver neoplasms, and their induction is predictive of carcinogenic potential (39), as in this case.
In striking contrast to tamoxifen, toremifene was not only lacking in hepatocarcinogenic activity at daily doses ranging from 11 to 48 mg/kg but, in addition, this drug reduced the incidence of altered liver cell loci at the various interim sacrifice stages. This inhibitory effect on the development of liver foci was evident at 3 months using GST-P immunoreactivity and at 12 months by conventional H&E staining. The main type of focus suppressed by toremifene was the type des- ignated as having a tigroid pattern of staining (28). [/quote]
Going to head down to Tijuana again and see if I can find some of this toremifene. If I can’t maybe I’ll just do 6mg Clomid again for awhile. Not going near Nolvadex.
(read all the way to the bottom. there’s one naysayer in the thread, but the overall consensus is stay away from it)